Craig Pratt, MD

Professor of Cardiology, Institute for Academic Medicine
Full Member, Research Institute
Program Director, Cardiovascular Disease Residency, Department of Cardiology
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Craig Pratt, a clinical cardiologist, serves as medical director of the Cardiac Care Unit and EKG lab, and as director of research in the Houston Methodist DeBakey Heart & Vascular Center at Houston Methodist Hospital.

Dr. Pratt serves on a number of national and international committees. He is a consultant to the Center for Drug Evaluation and Research for the Food and Drug Administration (FDA); the Cardiovascular and Renal Drugs Advisory Board; and Center for Drug Evaluation and Research, a contributor to the North American Society for Pacing and Electrophysiology and various committees of the National Heart, Lung & Blood Institute. He is a fellow in the American College of Cardiology.

Dr. Pratt is a frequent contributor to publications, having authored over 300 journal articles, books, chapters and abstracts. Dr. Pratt received his medical degree from the University of California - Irvine. He completed residencies in internal medicine and a fellowship in cardiology at the University of California - Davis.

Lieutenant, US Naval Reserve, Camp Pendleton, CA; Director, Hypertension Clinic; Director, Outpatient Medical Services; Medical Advisor to Base General on Marine Weight Loss and Fitness Program; Director, Medical Clinic Services for Vietnam Refugees.

Description of Research

Dr. Pratt’s practice is dedicated to advancing cardiac patient care and clinical research. As director of research in the Methodist DeBakey Heart & Vascular Center, he leads and supports a team of physicians that together are today conducting more than 200 clinical studies across a wide range of cardiac-related topics. Dr. Pratt’s specific research interests are in clinical investigation of cardiac arrhythmias.

Areas Of Expertise

Cardiac arrhythmia Cardiovascular disease
Education & Training

Clinical Fellowship , University of California Davis
Residency , University of California Davis
Internship , University of California Davis
MD , University of California School of Medicine
Publications

Value of CACS compared with ETT and myocardial perfusion imaging for predicting long-term cardiac outcome in asymptomatic and symptomatic patients at low risk for coronary disease: Clinical implications in a multimodality imaging world
Chang, SM , Nabi, F , Xu, J , Pratt, CM, Mahmarian, AC, Frias, ME & Mahmarian, JJ 2015, JACC: Cardiovascular Imaging, vol 8, no. 2, pp. 134-144. DOI: 10.1016/j.jcmg.2014.11.008

New agents to prevent strokes in nonvalvular atrial fibrillation.
Putney, D & Pratt, C 2012, Houston Methodist DeBakey Cardiovascular Journal, vol 8, no. 3, pp. 44-46.

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: A randomized controlled trial
Kowey, PR, Reiffel, JA, Ellenbogen, KA, Naccarelli, GV & Pratt, CM 2010, JAMA: The Journal of the American Medical Association, vol 304, no. 21, pp. 2363-2372. DOI: 10.1001/jama.2010.1735

Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation
Pratt, CM, Roy, D, Torp-Pedersen, C, Wyse, DG, Toft, E, Juul-Moller, S, Retyk, E & Drenning, DH 2010, American Journal of Cardiology, vol 106, no. 9, pp. 1277-1283. DOI: 10.1016/j.amjcard.2010.06.054

Coronary artery calcium scoring in the emergency department: Identifying which patients with chest pain can be safely discharged home
Nabi, F , Chang, SM , Pratt, CM , Paranilam, J , Peterson, LE, Frias, ME & Mahmarian, JJ 2010, Annals of Emergency Medicine, vol 56, no. 3, pp. 220-229. DOI: 10.1016/j.annemergmed.2010.01.017

Warfarin and Aspirin Use in Atrial Fibrillation Among Practicing Cardiologist (from the AFFECTS Registry)
Kowey, PR, Reiffel, JA, Myerburg, R, Naccarelli, GV, Packer, DL, Pratt, CM, Reiter, MJ & Waldo, AL 2010, American Journal of Cardiology, vol 105, no. 8, pp. 1130-1134. DOI: 10.1016/j.amjcard.2009.11.047

Practice Patterns Among United States Cardiologists for Managing Adults With Atrial Fibrillation (from the AFFECTS Registry)
Reiffel, JA, Kowey, PR, Myerburg, R, Naccarelli, GV, Packer, DL, Pratt, CM, Reiter, MJ & Waldo, AL 2010, American Journal of Cardiology, vol 105, no. 8, pp. 1122-1129. DOI: 10.1016/j.amjcard.2009.11.046

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery a randomized, double-blind, placebo-controlled trial
Kowey, PR, Dorian, P, Mitchell, LB, Pratt, CM, Roy, D, Schwartz, PJ, Sadowski, J, Sobczyk, D, Bochenek, A & Toft, E 2009, Circulation: Arrhythmia and Electrophysiology, vol 2, no. 6, pp. 652-659. DOI: 10.1161/CIRCEP.109.870204

The Coronary Artery Calcium Score and Stress Myocardial Perfusion Imaging Provide Independent and Complementary Prediction of Cardiac Risk
Chang, SM , Nabi, F , Xu, J , Peterson, LE, Achari, A, Pratt, CM & Mahmarian, JJ 2009, Journal of the American College of Cardiology, vol 54, no. 20, pp. 1872-1882. DOI: 10.1016/j.jacc.2009.05.071

Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: A prospective study
Pratt, CM, Reiffel, JA, Ellenbogen, KA, Naccarelli, GV & Kowey, PR 2009, American Heart Journal, vol 158, no. 2. DOI: 10.1016/j.ahj.2009.05.024

Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial
Dorian, P, Al-Khalidi, HR, Hohnloser, SH, Brum, JM, Dunnmon, PM, Pratt, CM, Holroyde, MJ & Kowey, P 2008, Journal of the American College of Cardiology, vol 52, no. 13, pp. 1076-1083. DOI: 10.1016/j.jacc.2008.05.055

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial
Roy, D, Pratt, CM, Torp-Pedersen, C, Wyse, DG, Toft, E, Juul-Moller, S, Nielsen, T, Rasmussen, SL, Stiell, IG, Coutu, B, Ip, JH, Pritchett, ELC & Camm, AJ 2008, Circulation, vol 117, no. 12, pp. 1518-1525. DOI: 10.1161/CIRCULATIONAHA.107.723866

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
Torre-Amione, G, Anker, SD, Bourge, RC, Colucci, WS, Greenberg, BH, Hildebrandt, P, Keren, A, Motro, M, Moyé, LA, Otterstad, JE, Pratt, CM, Ponikowski, P, Rouleau, JL, Sestier, F, Winkelmann, BR & Young, JB 2008, The Lancet, vol 371, no. 9608, pp. 228-236. DOI: 10.1016/S0140-6736(08)60134-8

Myocardial perfusion imaging in identifying a low-risk group after acute myocardial infarction
Mahmarian, JJ & Pratt, CM 2007, Cardiology Review, vol 24, no. 7, pp. 19-24.

Reply
Mahmarian, JJ & Pratt, CM 2007, Journal of the American College of Cardiology, vol 49, no. 22, pp. 2227-2228. DOI: 10.1016/j.jacc.2007.03.023

Risk stratification after acute myocardial infarction: Is it time to reassess? Implications from the INSPIRE trial
Mahmarian, JJ & Pratt, CM 2007, Journal of Nuclear Cardiology, vol 14, no. 3, pp. 282-292. DOI: 10.1016/j.nuclcard.2007.04.007

A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: The ACCLAIM trial rationale and design
Torre-Amione, G, Bourge, RC, Colucci, WS, Greenberg, B, Pratt, C, Rouleau, JL, Sestier, F, Moyé, LA, Geddes, JA, Nemet, AJ & Young, JB 2007, Canadian Journal of Cardiology, vol 23, no. 5, pp. 369-376.

An Initial Strategy of Intensive Medical Therapy Is Comparable to That of Coronary Revascularization for Suppression of Scintigraphic Ischemia in High-Risk But Stable Survivors of Acute Myocardial Infarction
Mahmarian, JJ, Dakik, HA, Filipchuk, NG, Shaw, LJ, Iskander, SS, Ruddy, TD, Keng, F, Henzlova, MJ, Allam, A, Moyé, LA & Pratt, CM 2006, Journal of the American College of Cardiology, vol 48, no. 12, pp. 2458-2467. DOI: 10.1016/j.jacc.2006.07.068

A Multinational Study to Establish the Value of Early Adenosine Technetium-99m Sestamibi Myocardial Perfusion Imaging in Identifying a Low-Risk Group for Early Hospital Discharge After Acute Myocardial Infarction
Mahmarian, JJ, Shaw, LJ, Filipchuk, NG, Dakik, HA, Iskander, SS, Ruddy, TD, Henzlova, MJ, Keng, F, Allam, A, Moyé, LA & Pratt, CM 2006, Journal of the American College of Cardiology, vol 48, no. 12, pp. 2448-2457. DOI: 10.1016/j.jacc.2006.07.069

Electrical storm in patients with an implantable defibrillator: Incidence, features, and preventive therapy: Insights from a randomized trial
Hohnloser, SH, Al-Khalidi, HR, Pratt, CM, Brum, JM, Tatla, DS, Tchou, P & Dorian, P 2006, European Heart Journal, vol 27, no. 24, pp. 3027-3032. DOI: 10.1093/eurheartj/ehl276